MYCOSTATIN

This brand name is authorized in Australia, Austria, Ireland, New Zealand, Spain.

Active ingredients

The drug MYCOSTATIN contains one active pharmaceutical ingredient (API):

1
UNII BDF1O1C72E - NYSTATIN
 

Nystatin is an antifungal antibiotic active against a wide range of yeasts and yeast-like fungi, including Candida albicans.

 
Read more about Nystatin

Medication package inserts

Below package inserts are available for further reading:

Document Type Information Source  
 MYCOSTATIN Oral suspension MPI, EU: SmPC Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
A07AA02 Nystatin A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07A Intestinal antiinfectives → A07AA Antibiotics
Discover more medicines within A07AA02

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
AU Pharmaceutical Benefits Scheme 10854G
ES Centro de información online de medicamentos de la AEMPS 28262
IE Health Products Regulatory Authority 57843, 60017
NZ Medicines and Medical Devices Safety Authority 1619

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.